To translate these insights into acne care, future randomised trials should adopt stepped-wedge designs that integrate pharmacodynamic readouts (follicular Zn2+ levels, lesional IL-1β) alongside long-term phototoxicity surveillance. This evidence concerns the gene IL1B and acne.